Cargando…
Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger
BACKGROUND: This study sought to evaluate patient-reported health-related quality of life following proton therapy for prostate cancer in men ≤60 years old. METHODS: Between August 2006 and January 2010, 262 hormone-naive men ≤60 years old were treated with definitive proton therapy for prostate can...
Autores principales: | Hoppe, Bradford S, Nichols, Romaine C, Henderson, Randal H, Morris, Christopher G, Williams, Christopher R, Costa, Joseph, Marcus, Robert B, Mendenhall, William M, Li, Zuofeng, Mendenhall, Nancy P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Subscription Services, Inc., A Wiley Company
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465790/ https://www.ncbi.nlm.nih.gov/pubmed/22253020 http://dx.doi.org/10.1002/cncr.27398 |
Ejemplares similares
-
Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?
por: Bryant, Curtis, et al.
Publicado: (2016) -
Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
por: Kil, Whoon Jong, et al.
Publicado: (2013) -
Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials
por: Henderson, Randal H., et al.
Publicado: (2013) -
Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy
por: Kharod, Shivam M., et al.
Publicado: (2021) -
Insurance Approval for Definitive Proton Therapy for Prostate Cancer
por: Mendenhall, William M., et al.
Publicado: (2021)